DaVita Inc.
DaVita operates dialysis clinics, primarily in the US, treating patients with kidney failure who need regular blood-cleaning treatments to survive. It runs over 3,200 facilities and serves roughly 300,000 patients per year.
Revenue comes from insurance reimbursements — about two-thirds from Medicare/Medicaid at regulated rates, and the rest from commercial insurers. The economics are lopsided: commercial insurance patients are only ~10% of the patient base but generate nearly all the US dialysis profits, since government reimbursement rates are much lower.
Employees78,000IPOOct 31, 1995SIC8092HQ2000 16th Street, Denver, CO, USA, 80202
to
Financials (EUR)
Profitability
Metric
Current
Margins
Gross Margin
32.4%
Operating Margin
14.9%
EBITDA Margin
19.8%
Net Margin
6.1%
OCF Margin
15.6%
FCF Margin
11.5%
Returns on Capital
ROE
—
ROA
4.8%
ROIC
10.4%
ROCE
14.1%
ROC (Greenblatt)
37.0%
3Y ROIIC
−149.2%
Consistency
Years Profitable / 10Y
10
Valuation
Metric
Current
Earnings Multiples
P/E (TTM)
14.66
Forward P/E
12.12
P/E ex-NRI
13.97
Shiller P/E (CAPE)
22.42
Cash Flow Multiples
P/FCF
7.88
P/OCF
5.77
P/Owner Earnings
10.35
FCF Yield
14.08%
Enterprise Value Multiples
EV / EBIT
12.61
EV / Forward EBIT
11.31
EV / EBITDA
9.38
EV / Forward EBITDA
8.36
EV / Revenue
1.86
EV / Forward Revenue
1.68
Asset / Sales
P/S
0.89
P/B
—
P/Tangible Book
—
Growth-Adjusted
PEG
1.07
Capital Returns
Metric
Current
Dividends
Dividend Yield (TTM)
0.00%
Forward Dividend Yield
0.00%
3Y Dividend Growth
0.0%
Payout Ratio
0.00
5Y Yield on Cost
0.00%
Buybacks & Dilution
3Y Buyback Ratio
8.80%
Combined
Shareholder Yield
7.34%
Balance Sheet
Metric
Current
Leverage
Debt / Equity
−17.52
Gross Debt / EBITDA
4.84
Cash / Debt
0.05
Equity / Assets
−0.04
Coverage
Interest Coverage
3.52
Short-Term Liquidity
Current Ratio
1.47
Quick Ratio
1.41
Cash Ratio
0.24
Composite Scores
Piotroski F-Score
6
Altman Z-Score
1.68
Split History
Date
Split
2013-09-09
2:1
Ex-date
Amount
Pay date
No dividend history found.
Date
Transcript
Type
2026-08-04
Q2 2026 DaVita Inc Earnings Call Transcript
Earnings Call
2026-05-05
Q1 2026 DaVita Inc Earnings Call Transcript
Earnings Call
2026-03-02
DaVita Inc at TD Cowen Healthcare Conference Transcript
Conference Presentations
2026-02-02
Q4 2025 DaVita Inc Earnings Call Transcript
Earnings Call
2025-10-29
Q3 2025 DaVita Inc Earnings Call Transcript
Earnings Call
2025-08-05
Q2 2025 DaVita Inc Earnings Call Transcript
Earnings Call
2025-05-12
Q1 2025 DaVita Inc Earnings Call Transcript
Earnings Call
2025-02-13
Q4 2024 DaVita Inc Earnings Call Transcript
Earnings Call
2024-10-29
Q3 2024 DaVita Inc Earnings Call Transcript
Earnings Call
2024-08-06
Q2 2024 DaVita Inc Earnings Call Transcript
Earnings Call
10 of 40
5-Step DuPont Analysis
ROE %
-148.17%
×
×
Net Margin %
6.05%
×
×
Operating Margin %
14.93%
Operating Income
€1.80B
÷
Revenue
€12.04B
×
Tax Burden
0.5772
Net Income
€729M
÷
Pretax Income
€1.26B
×
Interest Burden
0.7024
Pretax Income
€1.26B
÷
Operating Income
€1.80B
×
Asset Turnover
0.79
÷
Revenue
€12.04B
÷
Average Total Assets
€15.27B
Begin Total Assets
€15.17B
End Total Assets
€15.37B
×
Equity Multiplier
-31.03
÷
Avg Total Assets
€15.27B
÷
Avg Stockholders Equity
−€492M
Begin Equity
−€320M
End Equity
−€664M